Clinical Trial Update: Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development

View source ↗

Summary

A completed trial update on immunosuppressive therapy for sarcoidosis noting the development of lymphoma as an adverse outcome observed during the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Sarcoidosis

Snippet

Sponsor: Alexandria University | Conditions: Sarcoidosis Lung | Status: COMPLETED